openPR Logo
Press release

Scope of Panic Disorders Market Size, Status and Top Key Vendors (GSK, Teva, Sun Pharma, Mylan, Abbott, Baxter, Roche, Pfizer, Sanofi) | Forecast to 2028

10-12-2021 03:03 PM CET | Health & Medicine

Press release from: Data Bridge Market Research (DBMR)

Panic Disorders Market

Panic Disorders Market

Overview of Global Panic Disorders Market:

The Global Panic Disorders Market report is a skilful and deep analysis of the present situation and challenges. This report focuses on the key drivers, restraints, Market opportunities, threats and risks for Market major players. It makes available analysis of Market size, shares, growth, segmentation, revenue projection (USD Mn), and regional study till 2028. Analysis and discussion of important industry trends, Market size, and Market share estimates are mentioned in the report. Panic Disorders Market research document also conducts study on production capacity, consumption, import and export for all major regions across the globe.

The reliable Panic Disorders Market report offers a comprehensive overview of the global Market and contains thoughtful insights, facts, historical information, and statistically supported and industry-verified Market data. It also encompasses forecasts using a suitable set of predictions and distinct research methodologies. This industry report is a professional in-depth study on the current state of the Market. The Market report also contains the drivers and restraints for the Panic Disorders Market that are derived from SOWT analysis, and also shows what all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands that are driving the Market by systemic company profiles.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-panic-disorders-market .

The Global Panic Disorders Market will exhibit a CAGR of around 6.45% for the forecast period of 2021-2028.

According to the market report analysis, Panic Disorder is sudden and frequent anxiety and fear attacks. Panic disorders are the result of anxiety and stress. In this fast pacing world, everyone aims to be in their top forms. The cut-throat competition in the market makes it difficult to even survive in the market. Growth and expansion become a far-fetched dream. As a result, people develop stress, tension, and burden. The symptoms of panic disorders are sweating, trembling, and shortness of breath, nausea, heart palpations, and numbness.

The most significant key factors driving the growth of the Global Panic Disorders Market are rapid growth in the population, rising prevalence of anxiety and stress especially in the adult population, rising research and development proficiencies to provide the best treatment to patients.

The Global Panic Disorders Market is segmented on the basis of Type, Drug Class and Application.

Based on the Type, the panic disorders market is segmented into agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCS), bipolar disorder, post-traumatic stress disorder (PTSD), special phobias, generalized anxiety disorder and major depressive disorder.

Based on the Drug Class, the panic disorders market is segmented into selective serotonin reuptake inhibitor (SSRI), benzodiazepines (BZD) and serotonin-norepinephrine reuptake inhibitor (SNRI). Serotonin-norepinephrine reuptake inhibitor (SNRI) is further sub-segmented into paroxetine, fluoxetine and sertraline.

Based on the Application, the panic disorders market is segmented into hospital pharmacies, retail pharmacies, drug stores and e-commerce.

In terms of the geographic analysis, North America lions the panic disorders market owing to the high awareness for panic disorders across countries in the region. The U.S. has emerged to be the major stakeholder of all the countries in this region. Increasing acceptance of panic disorder treatment is another reason for the sustained dominance of this region. APAC on the other hand is set to undergo the highest compound annual growth rate during the forecast period.

Access Complete Report Here: https://www.databridgemarketresearch.com/reports/global-panic-disorders-market .

Global Panic Disorders Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Panic Disorders Market

2 To analyze and forecast the size of the Panic Disorders Market, in terms of value and volume

3 To analyze opportunities in the Panic Disorders Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Panic Disorders Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Panic Disorders Market

Top Leading Key Manufacturers are: Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., AstraZeneca, Abbott., Baxter., Bristol-Myers Squibb Company, Lilly., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Noven Pharmaceuticals, Inc., Pfizer Inc., Recordati Rare Diseases, SHIONOGI & Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Boehringer Ingelheim International GmbH., Bausch Health Companies Inc., H. Lundbeck A/S, Sanofi, Neurocrine Biosciences, Inc and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Panic Disorders in these regions, from 2013 to 2028 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Get a TOC of “Global Panic Disorders Market Report 2021” @ https://www.databridgemarketresearch.com/toc/?dbmr=global-panic-disorders-market .

Global Panic Disorders Market: Table of Contents

1 Report Overview 2021-2028

2 Global Growth Trends 2021-2028

3 Competition Landscape by Key Players

4 Global Panic Disorders Market Analysis by Regions

5 Global Panic Disorders Market Analysis by Type

6 Global Panic Disorders Market Analysis by Applications

7 Global Panic Disorders Market Analysis by End-User

8 Key Companies Profiled

9 Global Panic Disorders Market Manufacturers Cost Analysis

10 Marketing Channel, Distributors, and Customers

11 Market Dynamics

12 Global Panic Disorders Market Forecasts 2021-2028

13 Research Findings and Conclusion

14 Methodology and Data Source

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scope of Panic Disorders Market Size, Status and Top Key Vendors (GSK, Teva, Sun Pharma, Mylan, Abbott, Baxter, Roche, Pfizer, Sanofi) | Forecast to 2028 here

News-ID: 2426299 • Views:

More Releases from Data Bridge Market Research (DBMR)

Structural Health Monitoring Market Poised to Hit $10.27B by 2030, Growing at 17.9% CAGR
Structural Health Monitoring Market Poised to Hit $10.27B by 2030, Growing at 17 …
The Structural Health Monitoring Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Structural Health Monitoring market forward, including increasing market share,
Smart Retail Market to Grow at 23.12% CAGR from 2022 to 2030
Smart Retail Market to Grow at 23.12% CAGR from 2022 to 2030
The Smart Retail Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Smart Retail market forward, including increasing market share, dynamic segmentation,
Smart Speaker Market Growing at 10.1% CAGR, Reach $22.48B by 2030.
Smart Speaker Market Growing at 10.1% CAGR, Reach $22.48B by 2030.
The Smart Speaker Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Smart Speaker market forward, including increasing market share, dynamic segmentation,
Thermoelectric Materials Market to Grow at 8.89% CAGR Through 2032
Thermoelectric Materials Market to Grow at 8.89% CAGR Through 2032
The Thermoelectric Materials Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Thermoelectric Materials market forward, including increasing market share, dynamic segmentation,

All 5 Releases


More Releases for Panic

Rising Number Of Psychiatric Patients Expected To Drive Panic Disorder Market Gr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Panic Disorders Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size for panic disorders has seen a steady expansion. The market that's valued at $10.73 billion in 2024 is projected to increase to $11.19 billion in 2025, with a compound
Key Trend Reshaping the Panic Disorders Market in 2025: Pharmaceutical Companies …
What Are the Projections for the Size and Growth Rate of the Panic Disorders Market? The panic disorders market has seen steady growth in recent years. It will grow from $10.73 billion in 2024 to $11.19 billion in 2025, at a CAGR of 4.3%. The growth is attributed to the availability of antidepressant medications, increased mental health awareness, rising stress levels, improved access to mental health services, and advancements in diagnostic
Panic Disorders Market Comprehensive Survey 2025
Global Panic Disorders Market: Snapshot Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. These attacks are sudden and can affect the health of a person on a serious note if untreated. As a result, several drugs and therapeutics have been introduced in order to treat patients suffering from panic disorders across the globe. The rising demand for effective drugs and the rising awareness regarding its
Dealing with Pandemic Panic Free Webinar
Princeton NJ, April 14, 2020 Join psychiatrist Peter A. Crist, M.D. for "Dealing with Pandemic Panic: The Fresh Approach of Medical Orgone Therapy," a timely free on-line webinar on Saturday, April 18, 2020 starting at 4:00PM and lasting approximately one hour. Dr. Crist, president of the American College of Orgonomy (ACO), will talk about emotional reactions to the pandemic, how his patients are dealing with it, and how
PASSFEED CALMS CONSUMERS' 'PANIC BUYING'
(New York, NY) March 13, 2020 -- It's Friday the 13th; an ominous day that would have superstitious people a little more cautious as they head out for the weekend. Unfortunately, much bigger threats have taken affect and instilled fear in the public's eye, which has led to widespread "panic buying" amid growing cases and concerns of Coronavirus disease (COVID-19). Shelves are empty for toiletries as consumers continue to buy
Panic Disorders Market: Industry Survey and Outlook 2025
Global Panic Disorders Market: Snapshot Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. These attacks are sudden and can affect the health of a person on a serious note if untreated. As a result, several drugs and therapeutics have been introduced in order to treat patients suffering from panic disorders across the globe. The rising demand for effective drugs and the rising awareness regarding its